Table 3.

Risk Associations of Hospital-onset Clostridioides difficile Infection Determined by Unadjusted Bivariate Analysis (N = 8763)

CharacteristicOR (95% CI)P Value
Demographics
 Age ≥65 y1.27 (.75–2.14).4
 Male sex1.20 (.71–2.03).5
 Intensive care unit3.31 (1.62–6.77).001
Concomitant medications
 Metronidazole1.00 (.47–2.1)1.0
 Proton pump inhibitor1.78 (1.05–3.01).03
Intervention
Saccharomyces boulardii and antibiotic 0.68 (.41–1.1) .2
CharacteristicOR (95% CI)P Value
Demographics
 Age ≥65 y1.27 (.75–2.14).4
 Male sex1.20 (.71–2.03).5
 Intensive care unit3.31 (1.62–6.77).001
Concomitant medications
 Metronidazole1.00 (.47–2.1)1.0
 Proton pump inhibitor1.78 (1.05–3.01).03
Intervention
Saccharomyces boulardii and antibiotic 0.68 (.41–1.1) .2

Abbreviations: CI, confidence interval; HO-CDI, hospital-onset Clostridioides difficile infection; OR, odds ratio.

Table 3.

Risk Associations of Hospital-onset Clostridioides difficile Infection Determined by Unadjusted Bivariate Analysis (N = 8763)

CharacteristicOR (95% CI)P Value
Demographics
 Age ≥65 y1.27 (.75–2.14).4
 Male sex1.20 (.71–2.03).5
 Intensive care unit3.31 (1.62–6.77).001
Concomitant medications
 Metronidazole1.00 (.47–2.1)1.0
 Proton pump inhibitor1.78 (1.05–3.01).03
Intervention
Saccharomyces boulardii and antibiotic 0.68 (.41–1.1) .2
CharacteristicOR (95% CI)P Value
Demographics
 Age ≥65 y1.27 (.75–2.14).4
 Male sex1.20 (.71–2.03).5
 Intensive care unit3.31 (1.62–6.77).001
Concomitant medications
 Metronidazole1.00 (.47–2.1)1.0
 Proton pump inhibitor1.78 (1.05–3.01).03
Intervention
Saccharomyces boulardii and antibiotic 0.68 (.41–1.1) .2

Abbreviations: CI, confidence interval; HO-CDI, hospital-onset Clostridioides difficile infection; OR, odds ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close